Monte Rosa Therapeutics Inc (GLUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 4,210 | 2,781 | 12,768 | 23,194 | 84,929 |
| Gross Profit | 4,210 | 2,781 | 12,768 | 23,194 | 84,929 |
| Operating Expenses | 54,244 | 52,496 | 45,743 | 38,748 | 40,893 |
| Operating Income | -50,034 | -49,715 | -32,975 | -15,554 | 44,036 |
| Other Income | 5,583 | 3,639 | 2,717 | 4,458 | 3,671 |
| Pre-tax Income | -44,451 | -46,076 | -30,258 | -11,096 | 47,707 |
| Income Tax | 52 | 59 | -3,177 | 1,199 | 822 |
| Net Income Continuous | -44,503 | -46,135 | -27,081 | -12,295 | 46,885 |
| Net Income | $-44,503 | $-46,135 | $-27,081 | $-12,295 | $46,885 |
| EPS Basic Total Ops | -0.45 | -0.55 | -0.33 | -0.15 | 0.57 |
| EPS Basic Continuous Ops | -0.45 | -0.56 | -0.33 | -0.15 | 0.57 |
| EPS Diluted Total Ops | -0.45 | -0.55 | -0.33 | -0.15 | 0.57 |
| EPS Diluted Continuous Ops | -0.45 | -0.55 | -0.33 | -0.15 | 0.57 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.55 | -0.33 | -0.15 | 0.57 |
| EBITDA(a) | $-48,005 | $-47,627 | $-30,880 | $-13,429 | $46,084 |